Hippocampal neurons isolated from rats subjected to the valproic acid model mimic in vivo synaptic pattern: evidence of neuronal priming during early development in autism spectrum disorders.
Animals
Anticonvulsants
Autism Spectrum Disorder
/ chemically induced
Behavior, Animal
/ drug effects
Cells, Cultured
Disease Models, Animal
Female
Hippocampus
/ drug effects
Male
Microglia
/ drug effects
Neural Cell Adhesion Molecules
/ metabolism
Neuronal Plasticity
/ drug effects
Neurons
/ drug effects
Phosphoprotein Phosphatases
/ metabolism
Pregnancy
Rats, Wistar
Synapses
/ drug effects
Valproic Acid
Adhesion molecules
Autism spectrum disorders
Hippocampus
NCAM
Synapse
VPA model
Journal
Molecular autism
ISSN: 2040-2392
Titre abrégé: Mol Autism
Pays: England
ID NLM: 101534222
Informations de publication
Date de publication:
06 03 2021
06 03 2021
Historique:
received:
09
10
2020
accepted:
22
02
2021
entrez:
7
3
2021
pubmed:
8
3
2021
medline:
10
11
2021
Statut:
epublish
Résumé
Autism spectrum disorders (ASD) are synaptopathies characterized by area-specific synaptic alterations and neuroinflammation. Structural and adhesive features of hippocampal synapses have been described in the valproic acid (VPA) model. However, neuronal and microglial contribution to hippocampal synaptic pattern and its time-course of appearance is still unknown. Male pups born from pregnant rats injected at embryonic day 10.5 with VPA (450 mg/kg, i.p.) or saline (control) were used. Maturation, exploratory activity and social interaction were assessed as autistic-like traits. Synaptic, cell adhesion and microglial markers were evaluated in the CA3 hippocampal region at postnatal day (PND) 3 and 35. Primary cultures of hippocampal neurons from control and VPA animals were used to study synaptic features and glutamate-induced structural remodeling. Basal and stimuli-mediated reactivity was assessed on microglia primary cultures isolated from control and VPA animals. At PND3, before VPA behavioral deficits were evident, synaptophysin immunoreactivity and the balance between the neuronal cell adhesion molecule (NCAM) and its polysialylated form (PSA-NCAM) were preserved in the hippocampus of VPA animals along with the absence of microgliosis. At PND35, concomitantly with the establishment of behavioral deficits, the hippocampus of VPA rats showed fewer excitatory synapses and increased NCAM/PSA-NCAM balance without microgliosis. Hippocampal neurons from VPA animals in culture exhibited a preserved synaptic puncta number at the beginning of the synaptogenic period in vitro but showed fewer excitatory synapses as well as increased NCAM/PSA-NCAM balance and resistance to glutamate-induced structural synaptic remodeling after active synaptogenesis. Microglial cells isolated from VPA animals and cultured in the absence of neurons showed similar basal and stimuli-induced reactivity to the control group. Results indicate that in the absence of glia, hippocampal neurons from VPA animals mirrored the in vivo synaptic pattern and suggest that while neurons are primed during the prenatal period, hippocampal microglia are not intrinsically altered. Our study suggests microglial role is not determinant for developing neuronal alterations or counteracting neuronal outcome in the hippocampus and highlights the crucial role of hippocampal neurons and structural plasticity in the establishment of the synaptic alterations in the VPA rat model.
Sections du résumé
BACKGROUND
Autism spectrum disorders (ASD) are synaptopathies characterized by area-specific synaptic alterations and neuroinflammation. Structural and adhesive features of hippocampal synapses have been described in the valproic acid (VPA) model. However, neuronal and microglial contribution to hippocampal synaptic pattern and its time-course of appearance is still unknown.
METHODS
Male pups born from pregnant rats injected at embryonic day 10.5 with VPA (450 mg/kg, i.p.) or saline (control) were used. Maturation, exploratory activity and social interaction were assessed as autistic-like traits. Synaptic, cell adhesion and microglial markers were evaluated in the CA3 hippocampal region at postnatal day (PND) 3 and 35. Primary cultures of hippocampal neurons from control and VPA animals were used to study synaptic features and glutamate-induced structural remodeling. Basal and stimuli-mediated reactivity was assessed on microglia primary cultures isolated from control and VPA animals.
RESULTS
At PND3, before VPA behavioral deficits were evident, synaptophysin immunoreactivity and the balance between the neuronal cell adhesion molecule (NCAM) and its polysialylated form (PSA-NCAM) were preserved in the hippocampus of VPA animals along with the absence of microgliosis. At PND35, concomitantly with the establishment of behavioral deficits, the hippocampus of VPA rats showed fewer excitatory synapses and increased NCAM/PSA-NCAM balance without microgliosis. Hippocampal neurons from VPA animals in culture exhibited a preserved synaptic puncta number at the beginning of the synaptogenic period in vitro but showed fewer excitatory synapses as well as increased NCAM/PSA-NCAM balance and resistance to glutamate-induced structural synaptic remodeling after active synaptogenesis. Microglial cells isolated from VPA animals and cultured in the absence of neurons showed similar basal and stimuli-induced reactivity to the control group. Results indicate that in the absence of glia, hippocampal neurons from VPA animals mirrored the in vivo synaptic pattern and suggest that while neurons are primed during the prenatal period, hippocampal microglia are not intrinsically altered.
CONCLUSIONS
Our study suggests microglial role is not determinant for developing neuronal alterations or counteracting neuronal outcome in the hippocampus and highlights the crucial role of hippocampal neurons and structural plasticity in the establishment of the synaptic alterations in the VPA rat model.
Identifiants
pubmed: 33676530
doi: 10.1186/s13229-021-00428-8
pii: 10.1186/s13229-021-00428-8
pmc: PMC7937248
doi:
Substances chimiques
Anticonvulsants
0
Neural Cell Adhesion Molecules
0
Valproic Acid
614OI1Z5WI
microtubule-associated protein-2 phosphatase
EC 3.1.3.-
Phosphoprotein Phosphatases
EC 3.1.3.16
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
23Références
J Autism Dev Disord. 2001 Dec;31(6):537-43
pubmed: 11814263
Brain. 2001 Jul;124(Pt 7):1317-24
pubmed: 11408327
Annu Rev Cell Dev Biol. 2018 Oct 6;34:523-544
pubmed: 30089221
Mol Psychiatry. 2002;7(3):302-10
pubmed: 11920157
Front Aging Neurosci. 2017 Aug 31;9:277
pubmed: 28912710
Front Pediatr. 2018 Sep 26;6:264
pubmed: 30320048
Neurotoxicology. 2018 Mar;65:1-8
pubmed: 29309796
Front Cell Neurosci. 2018 Jul 24;12:215
pubmed: 30087595
Behav Brain Res. 2017 Jan 1;316:279-293
pubmed: 27613230
Mol Autism. 2017 Mar 17;8:13
pubmed: 28331572
J Neurochem. 2010 Sep 1;114(5):1414-23
pubmed: 20557420
J Pineal Res. 2014 Jan;56(1):1-11
pubmed: 23952810
Brain Behav Immun. 2014 Mar;37:1-14
pubmed: 24412599
Nat Rev Neurosci. 2007 Mar;8(3):206-20
pubmed: 17299456
Cerebellum. 2009 Mar;8(1):64-9
pubmed: 19002745
Neuron. 2001 Oct 11;32(1):63-77
pubmed: 11604139
Anat Rec. 1991 Dec;231(4):482-97
pubmed: 1793176
Front Behav Neurosci. 2018 Aug 21;12:182
pubmed: 30186123
Science. 2011 Sep 9;333(6048):1456-8
pubmed: 21778362
Science. 2018 Oct 12;362(6411):181-185
pubmed: 30309945
Exp Neurol. 2018 Jan;299(Pt A):217-227
pubmed: 28472621
Neuron. 2000 Jan;25(1):93-107
pubmed: 10707975
Brain Behav Immun. 2017 May;62:193-202
pubmed: 28159644
Mol Brain. 2015 Feb 15;8:10
pubmed: 25757474
Sci Rep. 2018 Jan 16;8(1):828
pubmed: 29339791
Brain Res. 2019 Apr 1;1708:188-199
pubmed: 30537517
J Toxicol Sci. 2018;43(11):631-643
pubmed: 30404997
Sci Transl Med. 2019 Feb 27;11(481):
pubmed: 30814340
J Pharmacol Sci. 2016 Oct;132(2):115-121
pubmed: 27818011
Brain Res Rev. 2007 Nov;56(1):101-18
pubmed: 17658613
Mol Psychiatry. 2005 Feb;10(2):160-84
pubmed: 15356639
World J Biol Psychiatry. 2016 Apr;17(3):174-86
pubmed: 26469219
Trends Neurosci. 1997 Nov;20(11):523-9
pubmed: 9364667
Eur Arch Psychiatry Clin Neurosci. 2013 Aug;263(5):379-84
pubmed: 22986449
PLoS One. 2014 Oct 03;9(10):e108921
pubmed: 25279838
J Autism Dev Disord. 2012 Dec;42(12):2569-84
pubmed: 22466688
Life Sci. 2017 Mar 15;173:43-54
pubmed: 28161158
Neural Dev. 2018 May 1;13(1):7
pubmed: 29712572
Brain Res. 2015 Mar 10;1600:70-83
pubmed: 25452020
Adv Immunol. 2017;135:53-79
pubmed: 28826529
J Neuroinflammation. 2015 May 29;12:106
pubmed: 26022493
Front Neural Circuits. 2008 Oct 29;2:4
pubmed: 18989389
Front Syst Neurosci. 2011 Feb 22;5:10
pubmed: 21390284
Prog Neurobiol. 2006 Oct;80(3):129-64
pubmed: 17029752
Behav Brain Res. 2019 Feb 1;359:234-238
pubmed: 30423390
Front Cell Neurosci. 2018 Dec 21;12:470
pubmed: 30627085
Front Cell Neurosci. 2019 Aug 27;13:380
pubmed: 31507379
Front Aging Neurosci. 2019 May 31;11:123
pubmed: 31214013
Brain Res. 1973 Dec 7;63:195-204
pubmed: 4764297
Curr Opin Neurobiol. 2017 Feb;42:1-8
pubmed: 27788368
J Neurochem. 2003 Jun;85(5):1279-88
pubmed: 12753086
J Cell Biol. 2006 Sep 25;174(7):1071-85
pubmed: 17000882
Dev Neurosci. 2015;37(3):215-31
pubmed: 25895486
Synapse. 2014 Oct;68(10):468-73
pubmed: 24985713
J Neurosci. 2012 May 2;32(18):6323-34
pubmed: 22553038
J Mol Neurosci. 2018 May;65(1):1-9
pubmed: 29725984
Front Cell Neurosci. 2019 Aug 09;13:367
pubmed: 31447649
Mol Neurobiol. 2020 Aug;57(8):3424-3438
pubmed: 32529489
Brain Behav. 2015 Nov 11;5(12):e00403
pubmed: 26807334
Harv Rev Psychiatry. 2015 Jul-Aug;23(4):223-44
pubmed: 26146755
Acta Neurol Scand. 2010 Feb;121(2):99-108
pubmed: 19719810
Cell. 2007 Dec 14;131(6):1164-78
pubmed: 18083105
Dialogues Clin Neurosci. 2012 Sep;14(3):281-92
pubmed: 23226953
Neurotoxicol Teratol. 2013 Mar-Apr;36:47-56
pubmed: 23395807
Front Cell Neurosci. 2019 Oct 25;13:472
pubmed: 31708746
Science. 2003 Oct 31;302(5646):826-30
pubmed: 14593168
PLoS One. 2016 Jul 08;11(7):e0158688
pubmed: 27390857
BMC Neurosci. 2017 Jul 11;18(1):52
pubmed: 28821235
Nat Rev Neurosci. 2017 Nov;18(11):658-670
pubmed: 28931944
Ann Neurol. 2005 Jan;57(1):67-81
pubmed: 15546155
J Neurosci. 1994 Nov;14(11 Pt 1):6402-11
pubmed: 7965045
J Biol Chem. 2006 Nov 17;281(46):34859-69
pubmed: 16987814
J Autism Dev Disord. 2009 Feb;39(2):223-30
pubmed: 18821008
J Autism Dev Disord. 2001 Apr;31(2):183-94
pubmed: 11450817
Sci Adv. 2019 Jan 23;5(1):eaav0394
pubmed: 30746473
PLoS One. 2011 Jan 25;6(1):e15973
pubmed: 21283568
Brain Res. 2011 Mar 22;1380:218-28
pubmed: 20858465
J Neurosci. 2010 Mar 17;30(11):4171-83
pubmed: 20237287
J Neurochem. 2013 Mar;124(6):832-43
pubmed: 23311691
Trends Neurosci. 2017 May;40(5):295-308
pubmed: 28359630
J Am Acad Child Adolesc Psychiatry. 2020 Sep;59(9):1069-1079
pubmed: 31449875
Genet Test Mol Biomarkers. 2014 Oct;18(10):690-4
pubmed: 25137309
Hum Mol Genet. 2010 Oct 15;19(20):4072-82
pubmed: 20663923
Nat Neurosci. 2005 Jun;8(6):752-8
pubmed: 15895084
Acta Neuropathol. 1996;91(1):117-9
pubmed: 8773156
Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13501-6
pubmed: 17675408
Front Cell Neurosci. 2016 Nov 17;10:263
pubmed: 27909399
PLoS One. 2012;7(4):e35003
pubmed: 22558107
Neuroscience. 2013 Jun 25;241:170-87
pubmed: 23535253
Biol Psychiatry. 2010 Aug 15;68(4):368-76
pubmed: 20674603
Neuropsychopharmacology. 2005 Jan;30(1):80-9
pubmed: 15238991
Transl Psychiatry. 2018 May 25;8(1):106
pubmed: 29802263
Behav Brain Res. 2017 Aug 30;333:67-73
pubmed: 28655565
J Biol Chem. 2008 Jan 18;283(3):1463-1471
pubmed: 18045870
Pediatrics. 2011 Aug;128(2):344-55
pubmed: 21746727
Nat Neurosci. 2014 Mar;17(3):400-6
pubmed: 24487234
Brain Res. 2010 Jan 14;1309:83-94
pubmed: 19896929
Nat Rev Neurosci. 2008 Jan;9(1):26-35
pubmed: 18059411
Mol Psychiatry. 2017 Jun;22(6):820-835
pubmed: 27378147
J Neurosci. 1988 Apr;8(4):1454-68
pubmed: 3282038
Top Curr Chem. 2015;366:55-96
pubmed: 23715636
J Neurodev Disord. 2009 Jun;1(2):172-81
pubmed: 20664807
Hippocampus. 2018 Sep;28(9):672-679
pubmed: 28843041
J Cell Biol. 1963 Apr;17:208-12
pubmed: 13986422
Neuron. 2012 May 24;74(4):691-705
pubmed: 22632727
Mol Autism. 2018 Dec 27;9:66
pubmed: 30603062
Semin Cell Dev Biol. 2019 Oct;94:112-120
pubmed: 31077796
Am J Psychiatry. 2006 Dec;163(12):2189-92
pubmed: 17151175
Genes Brain Behav. 2003 Oct;2(5):255-67
pubmed: 14606691